About nuwellis inc - CHFS
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
CHFS At a Glance
Nuwellis, Inc.
12988 Valley View Road
Eden Prairie, Minnesota 55344
| Phone | 1-952-345-4200 | Revenue | 8.27M | |
| Industry | Medical Specialties | Net Income | -17,521,000.00 | |
| Sector | Health Technology | Employees | 38 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
CHFS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.145 |
| Price to Book Ratio | 1.118 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.042 |
| Enterprise Value to Sales | 0.054 |
| Total Debt to Enterprise Value | 0.729 |
CHFS Efficiency
| Revenue/Employee | 217,631.579 |
| Income Per Employee | -461,078.947 |
| Receivables Turnover | 5.539 |
| Total Asset Turnover | 1.035 |
CHFS Liquidity
| Current Ratio | 1.71 |
| Quick Ratio | 1.08 |
| Cash Ratio | 0.358 |
CHFS Profitability
| Gross Margin | 61.959 |
| Operating Margin | -134.293 |
| Pretax Margin | -211.802 |
| Net Margin | -211.862 |
| Return on Assets | -219.259 |
| Return on Equity | -382.555 |
| Return on Total Capital | -592.326 |
| Return on Invested Capital | -367.548 |
CHFS Capital Structure
| Total Debt to Total Equity | 12.471 |
| Total Debt to Total Capital | 11.089 |
| Total Debt to Total Assets | 5.361 |
| Long-Term Debt to Equity | 2.553 |
| Long-Term Debt to Total Capital | 2.265 |